News Headlines
-
Global Reach For Biotechs: Avance Clinical Secures MOUs With Four Premier Taiwanese Trial Sites
3/24/2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, is pleased to announce the signing of four Memorandums of Understanding (MOUs) with key clinical trial sites in Taiwan this week.
-
Avance Clinical Expands In Asia With Taipei Office To Accelerate Biotech Clinical Trials
3/24/2025
Avance Clinical, the award-winning, full-service Contract Research Organization (CRO) specializing in delivering agile and accelerated clinical development solutions for global biotechs, has further strengthened its presence in Asia with the opening of an office in Taipei, Taiwan.
-
Novotech Partners With Kyungpook National University Hospital To Strengthen Clinical Trial Capabilities In South Korea
3/19/2025
Novotech, a global leading full-service clinical CRO, and Acrostar, a provider of Site Management Organization (SMO) services, have entered into a strategic partnership that will support clinical trials across NHUH’s prestigious institutions including the Advanced Clinical Trials Center, the KNUH main campus, and the Chilgok KNUH in South Korea.
-
Medable Is The First Digital Trial Vendor To Achieve Landmark CNIL Approval
3/10/2025
Learn how Medable’s eConsent and eCOA solutions have been approved for use in two clinical studies in eight countries outside of the European Union by France’s Commission Nationale de l’Informatique et des Libertés (CNIL).
- Simbec-Orion And Avance Clinical Consolidates Partnership With Memorandum Of Understanding 3/4/2025
-
ActiGraph And Hyfe Announce Availability Of New Digital Health Tool For Cough Monitoring
2/25/2025
PENSACOLA, FL, January 28, 2025 - ActiGraph, the global leader in wearable digital health technology for clinical research and development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.
-
Novotech Releases Comprehensive Report On Oncolytic Virus Therapy
1/30/2025
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment.
-
Novotech Releases Report On Current State Of Triple-Negative Breast Cancer Clinical Trials
1/30/2025
Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Triple-Negative Breast Cancer (TNBC). The report highlights significant advancements in therapeutic strategies, regional clinical trial activity, and evolving biomarkers driving innovative TNBC treatments.
-
Comparing Eye Exams In Mobile Settings To In-Office Exams
1/29/2025
2020 On-site, a Boston-based mobile optometry company whose mission is to expand access to high-quality vision care including clinical research, has completed its observational study to assess the quality of subjective refraction, autorefraction, and keratometry measurements in a mobile eye setting.
-
ActiGraph Accelerates Clinical Trial Modernization With Transformational Acquisition Of Biofourmis Life Science Business
1/22/2025
ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that delivers an AI-driven, digital trial platform tailored for the life science industry. The combined solution will create a market-leading, unified software and data ecosystem for the modernization of clinical research throughout the drug-product lifecycle and across therapeutic areas.